{"count": 27, "results": [{"_id": "33584319", "pmid": 33584319, "pmcid": "PMC7880161", "title": "Metformin: A Novel Weapon Against Inflammation", "journal": "Front Pharmacol", "authors": ["Bai B", "Chen H"], "date": "2021-01-29T00:00:00Z", "doi": "10.3389/fphar.2021.622262", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "622262", "score": 50263.293, "text_hl": "By comparison, there are still clinical perplexities to be addressed in repurposing @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@-driven @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic diseases@@@. ", "citations": {"NLM": "Bai B, Chen H. Metformin: A Novel Weapon Against Inflammation Front Pharmacol. 2021;12():622262. PMID: 33584319", "BibTeX": "@article{33584319, title={Metformin: A Novel Weapon Against Inflammation}, author={Bai B and Chen H}, journal={Front Pharmacol}, volume={12}, pages={622262}}"}}, {"_id": "36552855", "pmid": 36552855, "pmcid": "PMC9777391", "title": "Deciphering the Antifibrotic Property of Metformin", "journal": "Cells", "authors": ["Septembre-Malaterre A", "Boina C", "Douanier A", "Gasque P"], "date": "2022-12-16T00:00:00Z", "doi": "10.3390/cells11244090", "meta_date_publication": "2022 Dec 16", "meta_volume": "11", "meta_issue": "24", "meta_pages": "", "score": 50260.668, "text_hl": "Overall, these results show that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is a candidate molecule for antifibrotic effect and/or aiming to combat the development of @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic@@@ @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory diseases@@@ worldwide.", "citations": {"NLM": "Septembre-Malaterre A, Boina C, Douanier A, Gasque P. Deciphering the Antifibrotic Property of Metformin Cells. 2022 Dec 16;11(24):. PMID: 36552855", "BibTeX": "@article{36552855, title={Deciphering the Antifibrotic Property of Metformin}, author={Septembre-Malaterre A and Boina C and Douanier A and Gasque P}, journal={Cells}, volume={11}, number={24}}"}}, {"_id": "33562458", "pmid": 33562458, "pmcid": "PMC7915435", "title": "The Current and Potential Therapeutic Use of Metformin:The Good Old Drug", "journal": "Pharmaceuticals (Basel)", "authors": ["Drzewoski J", "Hanefeld M"], "date": "2021-02-05T00:00:00Z", "doi": "10.3390/ph14020122", "meta_date_publication": "2021 Feb 5", "meta_volume": "14", "meta_issue": "2", "meta_pages": "", "score": 50255.33, "text_hl": "Moreover, it focuses on the potential beneficial effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@T2DM@@@ and coexisting @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic diseases@@@. ", "citations": {"NLM": "Drzewoski J, Hanefeld M. The Current and Potential Therapeutic Use of Metformin:The Good Old Drug Pharmaceuticals (Basel). 2021 Feb 5;14(2):. PMID: 33562458", "BibTeX": "@article{33562458, title={The Current and Potential Therapeutic Use of Metformin:The Good Old Drug}, author={Drzewoski J and Hanefeld M}, journal={Pharmaceuticals (Basel)}, volume={14}, number={2}}"}}, {"_id": "32902818", "pmid": 32902818, "pmcid": "PMC7479299", "title": "A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin", "journal": "Geroscience", "authors": ["Justice JN", "Gubbi S", "Kulkarni AS", "Bartley JM", "Kuchel GA", "Barzilai N"], "date": "2021-06-01T00:00:00Z", "doi": "10.1007/s11357-020-00261-6", "meta_date_publication": "2021 Jun", "meta_volume": "43", "meta_issue": "3", "meta_pages": "1093-1112", "score": 50255.03, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ acts through a few widely accepted cellular and molecular mechanisms that are highly interdependent and implicated @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s downstream effects on immune response, @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic diseases@@@, and @DISEASE_Syndrome @DISEASE_MESH:D013577 @@@geriatric syndromes@@@ (Table 1). ", "citations": {"NLM": "Justice JN, Gubbi S, Kulkarni AS, Bartley JM, Kuchel GA, Barzilai N. A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin Geroscience. 2021 Jun;43(3):1093-1112. PMID: 32902818", "BibTeX": "@article{32902818, title={A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin}, author={Justice JN and Gubbi S and Kulkarni AS and Bartley JM and Kuchel GA and Barzilai N}, journal={Geroscience}, volume={43}, number={3}, pages={1093-1112}}"}}, {"_id": "35455439", "pmid": 35455439, "pmcid": "PMC9030054", "title": "A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer", "journal": "Pharmaceuticals (Basel)", "authors": ["Chow E", "Yang A", "Chung CHL", "Chan JCN"], "date": "2022-04-02T00:00:00Z", "doi": "10.3390/ph15040442", "meta_date_publication": "2022 Apr 2", "meta_volume": "15", "meta_issue": "4", "meta_pages": "", "score": 50252.457, "text_hl": "Further research into the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on cognitive function, @DISEASE_Infections @DISEASE_MESH:D007239 @@@infection@@@ and @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@, especially in people without @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, will provide new insights into the therapeutic value of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in our pursuit of prevention and treatment of ageing-related as well as acute and @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic diseases@@@ beyond @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@.", "citations": {"NLM": "Chow E, Yang A, Chung CHL, Chan JCN. A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer Pharmaceuticals (Basel). 2022 Apr 2;15(4):. PMID: 35455439", "BibTeX": "@article{35455439, title={A Clinical Perspective of the Multifaceted Mechanism of Metformin in Diabetes, Infections, Cognitive Dysfunction, and Cancer}, author={Chow E and Yang A and Chung CHL and Chan JCN}, journal={Pharmaceuticals (Basel)}, volume={15}, number={4}}"}}, {"_id": "33765548", "pmid": 33765548, "title": "The potential of drug-herbal interaction among patients with chronic diseases in Saudi Arabia.", "journal": "Complement Ther Clin Pract", "authors": ["Albassam AA", "Alanazi A", "Alhaqbani N", "Alhoti F", "Almalki ZS", "Alshehri AM", "Alzahrani J"], "date": "2021-05-01T00:00:00Z", "doi": "10.1016/j.ctcp.2021.101324", "meta_date_publication": "2021 May", "meta_volume": "43", "meta_issue": "", "meta_pages": "101324", "score": 50251.7, "text_hl": "The potential of drug-herbal interaction among @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic diseases@@@ in Saudi Arabia.", "citations": {"NLM": "Albassam AA, Alanazi A, Alhaqbani N, Alhoti F, Almalki ZS, Alshehri AM, Alzahrani J. The potential of drug-herbal interaction among patients with chronic diseases in Saudi Arabia. Complement Ther Clin Pract. 2021 May;43():101324. PMID: 33765548", "BibTeX": "@article{33765548, title={The potential of drug-herbal interaction among patients with chronic diseases in Saudi Arabia.}, author={Albassam AA and Alanazi A and Alhaqbani N and Alhoti F and Almalki ZS and Alshehri AM and Alzahrani J}, journal={Complement Ther Clin Pract}, volume={43}, pages={101324}}"}}, {"_id": "35064693", "pmid": 35064693, "title": "Metformin ameliorates chronic colitis in a mouse model by regulating interferon-gamma-producing lamina propria CD4+ T cells through AMPK activation.", "journal": "FASEB J", "authors": ["Takahara M", "Takaki A", "Hiraoka S", "Takei K", "Yasutomi E", "Igawa S", "Yamamoto S", "Oka S", "Ohmori M", "Yamasaki Y", "Inokuchi T", "Kinugasa H", "Harada K", "Udono H", "Okada H"], "date": "2022-02-01T00:00:00Z", "doi": "10.1096/fj.202100831RR", "meta_date_publication": "2022 Feb", "meta_volume": "36", "meta_issue": "2", "meta_pages": "e22139", "score": 50251.164, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic@@@ @DISEASE_Colitis @DISEASE_MESH:D003092 @@@colitis@@@ in a @SPECIES_10090 @@@mouse@@@ model by regulating @GENE_IFNG @GENE_15978 @@@interferon-gamma@@@-producing lamina propria @GENE_CD4 @GENE_12504 @@@CD4@@@+ T cells through AMPK activation.", "citations": {"NLM": "Takahara M, Takaki A, Hiraoka S, Takei K, Yasutomi E, Igawa S, Yamamoto S, Oka S, Ohmori M, Yamasaki Y, Inokuchi T, Kinugasa H, Harada K, Udono H, Okada H. Metformin ameliorates chronic colitis in a mouse model by regulating interferon-gamma-producing lamina propria CD4+ T cells through AMPK activation. FASEB J. 2022 Feb;36(2):e22139. PMID: 35064693", "BibTeX": "@article{35064693, title={Metformin ameliorates chronic colitis in a mouse model by regulating interferon-gamma-producing lamina propria CD4+ T cells through AMPK activation.}, author={Takahara M and Takaki A and Hiraoka S and Takei K and Yasutomi E and Igawa S and Yamamoto S and Oka S and Ohmori M and Yamasaki Y and Inokuchi T and Kinugasa H and Harada K and Udono H and Okada H}, journal={FASEB J}, volume={36}, number={2}, pages={e22139}}"}}, {"_id": "33561890", "pmid": 33561890, "title": "The effect of the anti-diabetic drug metformin on musculoskeletal pain: A cross-sectional study with 21,889 individuals from the UK biobank.", "journal": "Eur J Pain", "authors": ["Carvalho-E-Silva AP", "Harmer AR", "Ferreira ML", "Ferreira PH"], "date": "2021-07-01T00:00:00Z", "doi": "10.1002/ejp.1747", "meta_date_publication": "2021 Jul", "meta_volume": "25", "meta_issue": "6", "meta_pages": "1264-1273", "score": 50249.67, "text_hl": "Participants using @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ also had lower odds of reporting @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic@@@ multisite @DISEASE_Musculoskeletal_Pain @DISEASE_MESH:D059352 @@@musculoskeletal pain@@@. ", "citations": {"NLM": "Carvalho-E-Silva AP, Harmer AR, Ferreira ML, Ferreira PH. The effect of the anti-diabetic drug metformin on musculoskeletal pain: A cross-sectional study with 21,889 individuals from the UK biobank. Eur J Pain. 2021 Jul;25(6):1264-1273. PMID: 33561890", "BibTeX": "@article{33561890, title={The effect of the anti-diabetic drug metformin on musculoskeletal pain: A cross-sectional study with 21,889 individuals from the UK biobank.}, author={Carvalho-E-Silva AP and Harmer AR and Ferreira ML and Ferreira PH}, journal={Eur J Pain}, volume={25}, number={6}, pages={1264-1273}}"}}, {"_id": "32068434", "pmid": 32068434, "title": "Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.", "journal": "Child Obes", "authors": ["Sadeghi A", "Mousavi SM", "Mokhtari T", "Parohan M", "Milajerdi A"], "date": "2020-04-01T00:00:00Z", "doi": "10.1089/chi.2019.0040", "meta_date_publication": "2020 Apr", "meta_volume": "16", "meta_issue": "3", "meta_pages": "174-191", "score": 50247.156, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ therapy did not affect lean body mass (LBM) in @SPECIES_9606 @@@patients@@@ with @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@ or @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and growth problems; however, it reduced LBM in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic diseases@@@ (WMD: -1.49 kg; 95% CI: -2.69 to -0.30). ", "citations": {"NLM": "Sadeghi A, Mousavi SM, Mokhtari T, Parohan M, Milajerdi A. Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Child Obes. 2020 Apr;16(3):174-191. PMID: 32068434", "BibTeX": "@article{32068434, title={Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.}, author={Sadeghi A and Mousavi SM and Mokhtari T and Parohan M and Milajerdi A}, journal={Child Obes}, volume={16}, number={3}, pages={174-191}}"}}, {"_id": "38078688", "pmid": 38078688, "pmcid": "PMC10726377", "title": "Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea", "journal": "Acta Derm Venereol", "authors": ["Cho M", "Woo YR", "Cho SH", "Lee JD", "Kim HS"], "date": "2023-12-11T00:00:00Z", "doi": "10.2340/actadv.v103.18392", "meta_date_publication": "2023 Dec 11", "meta_volume": "103", "meta_issue": "", "meta_pages": "adv18392", "score": 50242.88, "text_hl": "Considering the anti-androgenic, anti-angiogenic, anti-fibrotic and antioxidant properties of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, it may have the potential to improve @<m>DISEASE_Chronic_Disease</m> @DISEASE_MESH:D002908 @@@chronic@@@ @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ @DISEASE_Skin_Diseases @DISEASE_MESH:D012871 @@@skin diseases@@@. ", "citations": {"NLM": "Cho M, Woo YR, Cho SH, Lee JD, Kim HS. Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea Acta Derm Venereol. 2023 Dec 11;103():adv18392. PMID: 38078688", "BibTeX": "@article{38078688, title={Metformin: A Potential Treatment for Acne, Hidradenitis Suppurativa and Rosacea}, author={Cho M and Woo YR and Cho SH and Lee JD and Kim HS}, journal={Acta Derm Venereol}, volume={103}, pages={adv18392}}"}}]}